Managers

Stem cell company Forever Labs attracts $2 mln

Forever Labs, a company that banks young adult stem cells, has secured $2 million in funding. The investors included Northwestern Mutual, Silicon Badia Ventures, Babel Ventures and DogVacay CEO and founder Aaron Hirschhorn.

Israel sees strong Q1 investments with rebound in cybersecurity

Blispay is said to seek $30 mln with Series B

Fifth Wall Ventures raises $60 mln toward its Fifth Wall Ventures Retail Fund

Fifth Wall Ventures has raised $60 million toward a $200 million Fifth Wall Ventures Retail Fund, according to a filing with the SEC.

Six months after debut, Tusk plans return to market for Fund II

Presidio View collects $2.6 mln for cannabis investments

Presidio View Capital Partners, a venture firm that invests in the cannabis industry, has raised $2.6 million for its inaugural fund, according to an SEC filing. The target is $15 million, according to Michael Clifton, co-founder of Presidio View Capital. The hard cap on Fund I is $25 million, the Form D said.

VC-backed Evelo Biosciences goes public

Cambridge, Massachusetts-based Evelo Biosciences, a biotech company, has raised $85 million for its IPO after pricing its 5.3 million shares at $16 per share. The stock began trading May 9, 2018 on the NASDAQ under the ticker symbol "EVLO." Morgan Stanley, Cowen and BMO Capital Markets are the lead underwriters. Evelo's pre-IPO backers included Flagship Pioneering, GV, Celgene, Mayo Clinic and Alexandria Venture Investments.

Female Founders Fund wraps up sophomore fund at $27 mln

Female Founders Fund has closed its second fund at $27 million. The fund will focus on female-founded tech companies in the enterprise and consumer tech sectors.

Digital healthcare company Murj fetches $8.5 mln

Santa Cruz, California-based Murj Inc, a digital healthcare company, has secured $8.5 million in funding. Longitude Capital led the round with participation from other investors that included True Ventures.

Escient Pharmaceuticals rakes in $40 mln Series A

San Diego-based Escient Pharmaceutials, a newly launched biotech company, has closed $40 million in Series A funding. The investors were The Column Group, 5AM Ventures and Osage University Partners.